Fluvoxamine augmentation in clozapine-resistant schizophrenia: An open pilot study

被引：38

作者：

Silver, H

Kushnir, M

Kaplan, A

机构：

[1] Flugelman (Mazra) Psychiat. Hospital, Doar Na Ashrat

[2] Flugelman (Mazra) Psychiat. Hospital, Doar Na Ashrat

来源：

BIOLOGICAL PSYCHIATRY | 1996年 / 40卷 / 07期

关键词：

clozapine; treatment-resistant; schizophrenia; augmentation; SSRI;

D O I：

10.1016/0006-3223(96)00170-9

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：671 / 674

页数：4

共 15 条

[11]

SILVER H, 1995, AM J PSYCHIAT, V152, P1098

[12] FLUVOXAMINE AUGMENTATION IN CHRONIC-SCHIZOPHRENIA - AN OPEN EXPLORATORY-STUDY [J].

SILVER, H ;

KAPLAN, A ;

KUSHNIR, M .

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1995, 10 (01) :59-63

[13] FLUVOXAMINE IMPROVES NEGATIVE SYMPTOMS IN TREATED CHRONIC-SCHIZOPHRENIA - AN ADD-ON DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].

SILVER, H ;

NASSAR, A .

BIOLOGICAL PSYCHIATRY, 1992, 31 (07) :698-704

[14] FACTOR-ANALYSIS OF SCHIZOPHRENIC SYMPTOMS AND COMPARISON OF DIFFERENT RATING-SCALES [J].

SILVER, H ;

DAVID, D ;

KAPLAN, M ;

HADJEZ, J ;

TUBI, N ;

DARNEL, A ;

CALEV, A ;

LERER, B .

SCHIZOPHRENIA RESEARCH, 1993, 10 (01) :67-75

[15] NEUROLEPTIC PLASMA-LEVELS [J].

VANPUTTEN, T ;

MARDER, SR ;

WIRSHING, WC ;

ARAVAGIRI, M ;

CHABERT, N .

SCHIZOPHRENIA BULLETIN, 1991, 17 (02) :197-216

← 1 2 →